Cristina C.
- Country
- Portugal
- Department
- gastroenterology
Research Overview
- A Phase 2b Randomized, Double-Blind Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults with Precirrhotic Nonalcoholic Steatohepatitis
- Evaluation of Risankizumab, ABBV-382, and Lutikizumab in Adult Patients with Moderate to Severe Crohn's Disease: A Phase 2a Multicenter Randomized Study
Data & Insights
Has run more than one trial at 13 of 155 partner sites.
Specializations
Inflammatory Bowel Disease
Specializes in investigating therapeutic approaches for Crohn's Disease, with particular emphasis on managing moderate to severe manifestations of the condition.
- Targeted therapeutic interventions
- Inflammatory bowel disorders
- Disease severity assessment
Explores advanced treatment modalities for gastrointestinal inflammatory conditions through innovative therapeutic applications.
Therapeutic Development
Focuses on evaluating targeted therapies for inflammatory conditions, with specific attention to safety profiles and therapeutic efficacy.
- Treatment efficacy assessment
- Safety monitoring protocols
- Clinical response evaluation
Investigates mechanistic profiles of novel therapeutic approaches in gastrointestinal medicine.
Clinical Assessment
Specializes in evaluating treatment outcomes and therapeutic responses in inflammatory bowel conditions.
- Disease activity monitoring
- Treatment response assessment
- Patient outcome evaluation
Conducts comprehensive assessments of therapeutic interventions in gastroenterological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.